Copyright
©The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Clin Oncol. Dec 10, 2015; 6(6): 295-298
Published online Dec 10, 2015. doi: 10.5306/wjco.v6.i6.295
Published online Dec 10, 2015. doi: 10.5306/wjco.v6.i6.295
Carcinoma of unknown primary and paraneoplastic dermatomyositis
Amir Sonnenblick, Sharett Institute of Oncology, Medical Center of Hadassah-Hebrew University, Ein Kerem, Jerusalem 91120, Israel
Author contributions: Sonnenblick A designed and performed research; analyzed the data and wrote the paper.
Conflict-of-interest statement: The author has no conflicts of interest to declare.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Dr. Amir Sonnenblick, Sharett Institute of Oncology, Medical Center of Hadassah-Hebrew University, P.O. Box 12000, Ein Kerem, Jerusalem 91120, Israel. amirsonn@gmail.com
Telephone: +972-2-6757729
Received: April 17, 2015
Peer-review started: April 21, 2015
First decision: June 3, 2015
Revised: September 14, 2015
Accepted: October 12, 2015
Article in press: October 13, 2015
Published online: December 10, 2015
Processing time: 235 Days and 22.9 Hours
Peer-review started: April 21, 2015
First decision: June 3, 2015
Revised: September 14, 2015
Accepted: October 12, 2015
Article in press: October 13, 2015
Published online: December 10, 2015
Processing time: 235 Days and 22.9 Hours
Core Tip
Core tip: The presentation of carcinoma of unknown primary as dermatomyositis is rare. Positron emission tomography-computed tomography and pathology case oriented evaluation may identify the site of origin. We provide an up-to-date detailed review of published data describing these clinical entities.